Evidence map›Paper›PMID 41797682›Full record

ArticleJournal of viral hepatitis2026

Prolonged Intrahepatic Cholestasis After Acute Hepatitis E Infection: A Case Series and Genetic Analysis.

Montserrat Fraga, Sophie Kasmi, Susanne N Weber, Roman Liebe, Christine Sempoux, Ali Saadat, Jacques Fellay, Silke Kenngott-Kelber, Vincent Zimmer, Frank Lammert and 2 more

Abstract readCase Reports
In one paragraph

Article in Journal of viral hepatitis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Montserrat FragaDivision of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Sophie KasmiDivision of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0009-0004-3693-2827
Susanne N WeberDepartment of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
Roman LiebeDepartment of Gastroenterology, Hepatology and Transplant Medicine, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Christine SempouxInstitute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Ali SaadatSchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Jacques FellaySchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Silke Kenngott-KelberAbdominal Center Rüti, Rüti, Switzerland.
Vincent ZimmerDepartment of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
Frank LammertCenter for Health Economics Research Hannover (CHERH), Hannover Medical School (MHH), Hannover, Germany.
Marcin KrawczykDepartment of Gastroenterology, Hepatology and Transplant Medicine, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Christoph JüngstDepartment of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.ORCID https://orcid.org/0000-0001-5048-390X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide. Whereas HEV infection is typically self-limiting, rare cases of prolonged cholestasis have been reported. The underlying mechanisms remain unclear, though host genetic variation may contribute. This study aimed to investigate the role of genetic predisposition in HEV-induced prolonged cholestasis by analysing variants in genes associated with hepatocanalicular transport. We performed a retrospective review of medical records from three university centres in Switzerland and Germany and identified five immunocompetent patients with prolonged cholestasis following acute HEV infections. Genetic analysis using next-generation sequencing included a panel of five genes involved in cholestatic liver diseases (ATP8B1, ABCB11, ABCB4, ABCC2 and MYO5B). Variant frequencies were evaluated using population reference databases and compared with a genetically characterised cohort of asymptomatic HEV-infected blood donors. All five patients were male, with a median age of 59 years. The median duration of cholestasis exceeded 77 days. Two patients exhibited potentially pathogenic heterozygous variants: ATP8B1 p.N45T in one patient and MYO5B p.K429R in another. Additionally, common ABCB11 variants were detected in all patients, which might have contributed to cholestatic clinical presentation. In the asymptomatic HEV-infected controls, the MYO5B p.K429R variant was absent, whereas the ATP8B1 p.N45T variant was detected in only one individual in a heterozygous state. These case series illustrate that host genetics might influence the severity of HEV infection, particularly prolonged cholestatic jaundice. Further research is needed to explore the interaction between viral infections and host genetics in liver disorders.

Indexed as

Cholestasis, IntrahepaticGenetic Predisposition to DiseaseHepatitis EAdenosine TriphosphatasesAdultAgedATP-Binding Cassette Sub-Family B Member 4ATP Binding Cassette Transporter, Subfamily B, Member 11GermanyHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMultidrug Resistance-Associated Protein 2Myosin Type VRetrospective StudiesABCB11 protein, humanABCC2 protein, humanAdenosine TriphosphatasesATP8B1 protein, humanATP-Binding Cassette Sub-Family B Member 4ATP Binding Cassette Transporter, Subfamily B, Member 11Multidrug Resistance-Associated Protein 2Myosin Type VBRICcholestasisHEVhuman geneticsjaundice

Identifiers

PMID41797682
PMCPMC12969245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.